Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders

OBJECTIVE: Therapeutic drug monitoring helps clinicians in choosing the right drug and adjust its dose in specific patients. To this end, we aimed to assess time patterns of risperidone and its metabolite, 9-hydroxyrisperidone, in children and adolescents with oppositional defiant and/or conduct dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Piacentino, Daria, Kotzalidis, Georgios D., Schoretsanitis, Georgios, Paulzen, Michael, Haen, Ekkehard, Cappelletti, Simone, Giupponi, Giancarlo, Grözinger, Michael, Conca, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006987/
https://www.ncbi.nlm.nih.gov/pubmed/31958904
http://dx.doi.org/10.9758/cpn.2020.18.1.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006987/
https://www.ncbi.nlm.nih.gov/pubmed/31958904
http://dx.doi.org/10.9758/cpn.2020.18.1.41

Ejemplares similares